☆ 4.7 Review

Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals

Ahmed Fayed et al.

Summary: This study retrospectively analyzed patients with HCV-CryoVas treated with DAAs, finding that approximately 12.6% experienced vasculitis relapse after achieving sustained virologic response, predominantly showing skin involvement, renal involvement, and peripheral neuropathy. Relapses were mainly treated with glucocorticoids, with some patients requiring additional treatment modalities.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

LDL particle size and antioxidant HDL function improve after sustained virological response in patients with chronic HCV

Jose Ignacio Vargas et al.

Summary: In HCV patients receiving direct-acting antiviral treatment, changes in LDL particle size index and gradual improvement in HDL antioxidant capacity post-treatment may be mechanisms associated with reduced cardiovascular risk.

ANNALS OF HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response

Zobair M. Younossi et al.

Summary: Achieving sustained virologic response improves patient reported outcomes in patients with HCV cirrhosis. Patients with compensated cirrhosis have severe impairment in baseline PROs, but show significant improvement after achieving SVR. Patients with decompensated cirrhosis also experience improvement in PROs, but there is a declining trend after 2 years.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Adherence to regular surveillance visits for hepatocellular carcinoma in patients with chronic hepatitis C virus infection who achieved sustained virologic response

Hidenori Toyoda et al.

Summary: The adherence to post-SVR follow-up decreased over the long term, with significantly lower rates observed in patients who achieved SVR through interferon (IFN)-free therapy and those with HCV genotype 2b. Strategies are needed to encourage these patients to maintain regular hospital visits.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort

Loreta A. Kondili et al.

Summary: In patients with cryoglobulinemic vasculitis, achieving sustained virologic response (SVR) to HCV treatment does not always lead to consistent clinical improvement, as clinical response may vary over time. Post-SVR evaluation should be conducted carefully based on prognostic factors and tailored treatment approaches.

HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

Georg Semmler et al.

Summary: The study developed risk stratification algorithms for de novo HCC development after SVR in patients with ACLD. Parameters such as post-treatment AFP, alcohol consumption, age, LSM, and albumin accurately predicted de novo HCC development and stratified patients into low- and high-risk groups. These algorithms identified approximately two-thirds of patients with cACLD as having a low risk of <1%/year for HCC development, showing effectiveness in risk assessment and surveillance.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Editorial Material Gastroenterology & Hepatology

End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma

Ruben Hernaez et al.

GUT (2022)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

Victor Sapena et al.

Summary: This meta-analysis assessed the risk of HCC recurrence following DAA administration in HCV-related cirrhosis and HCC patients. Results showed an increased risk of recurrence and death in patients treated with DAAs, but no significant difference was observed in comparison to the DAA-unexposed group. Factors influencing recurrence included alpha-fetoprotein levels, pre-DAA recurrence history, patient performance status, and tumor burden.

GUT (2022)

Add to Collection

Review Medicine, General & Internal

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure

Mahmood Danishwar et al.

Summary: Treatment with direct acting antivirals (DAAs) has greatly improved HCV therapy, but cryoglobulinemic vasculitis (CryoVas) can persist and recur after HCV cure. This review found that 63.7% to 90.2% of patients achieved a complete clinical response (CR) after DAA treatment, but 4% to 18% experienced relapse of CryoVas symptoms. Neuropathy, nephropathy, and dermatological complications were the most common manifestations of CryoVas, and B-cell clones persisted in a significant percentage of patients, potentially contributing to relapse. Certain gene variants were associated with a higher incidence of CryoVas persistence and recurrence.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Urology & Nephrology

Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

Paul Martin et al.

Summary: This article discusses the adverse effects of hepatitis C virus infection in patients with chronic kidney disease and the recent advances in related treatments. The Work Group revised the 2018 guideline and highlights key aspects of the updated recommendations for the treatment, management, and diagnosis of kidney diseases associated with HCV infection.

KIDNEY INTERNATIONAL (2022)

Add to Collection

Article Endocrinology & Metabolism

HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus

Marina Angel et al.

Summary: This study compared HCV infection characteristics, treatment uptake, and treatment outcomes in patients with and without diabetes. The results showed that patients with diabetes were older and more likely to have cirrhosis. Treatment uptake and sustained virological response (SVR) were similar between the groups, but post-SVR hepatocellular carcinoma (HCC) risk was higher in the diabetes group.

BMC ENDOCRINE DISORDERS (2022)

Add to Collection

Review Gastroenterology & Hepatology

Breakthroughs in hepatitis C research: from discovery to cure

Michael P. Manns et al.

Summary: The history of hepatitis C virus (HCV) serves as a role model for successful research. From the discovery of an unknown virus in the 1970s to the development of direct antiviral agents, HCV research has made tremendous breakthroughs. The introduction of these agents revolutionized treatment and led to viral eradication in more than 98% of infected patients, making HCV the first curable chronic viral infection.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Review Virology

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection-From Drug Discovery to Successful Implementation in Clinical Practice

Christopher Dietz et al.

Summary: Hepatitis C virus infection poses a significant threat to human health, but the development of specific antiviral drugs has revolutionized the treatment and brought hope to patients.

VIRUSES-BASEL (2022)

Add to Collection

Article Gastroenterology & Hepatology

Non-invasive tests for clinically significant portal hypertension after HCV cure

Georg Semmler et al.

Summary: This study analyzed the diagnostic and prognostic value of non-invasive tests for portal hypertension in patients who have been cured of HCV infection. The results showed that liver stiffness measurement had an increased correlation with hepatic venous pressure gradient after treatment.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension

Heba Ahmed Faheem et al.

Summary: This study assessed the reversibility and improvement of portal hypertension in Egyptian patients with HCV-related cirrhosis after achieving sustained virologic response (SVR) with direct-acting antiviral agents (DAAs). The results showed that portal hypertension improved after SVR and completely regressed in some patients.

EGYPTIAN LIVER JOURNAL (2022)

Add to Collection

Article Gastroenterology & Hepatology

Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study

Marina Serper et al.

Summary: The study found that patients who achieved sustained virologic response (SVR) following HCV DAA therapy reported durable improvements in patient-reported outcomes at 12 months post-treatment, especially in fatigue, sleep, abdominal pain, and functional well-being. However, symptom improvements were generally not sustained among patients without SVR.

LIVER INTERNATIONAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity

Lisette A. P. Krassenburg et al.

Summary: In chronic HCV infection, DAA-induced SVR is associated with a reduced risk of clinical disease progression in patients with Child-Pugh A cirrhosis. However, in patients with Child-Pugh B/C cirrhosis, SVR does not seem to have an impact on clinical disease progression.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Diabetes Mellitus Increases the Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy: Systematic Review and Meta-Analysis

Szilard Vancsa et al.

Summary: DM is an independent risk factor of de novo HCC after DAA treatment in HCV-infected patients.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort

Vincenza Calvaruso et al.

Summary: This study evaluated the post-treatment survival of chronic HCV patients treated with DAAs and found that SVR was associated with reduced liver mortality risk and improved cardiovascular survival. Factors like platelet count and albumin value were also related to liver mortality risk, while diabetes and chronic kidney disease were identified as independent risk factors for cardiovascular mortality.

JOURNAL OF VIRAL HEPATITIS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes

Ferdinando Carlo Sasso et al.

Summary: This study demonstrates that HCV eradication by DAAs can significantly reduce the incidence of major cardiovascular events in prediabetic patients, highlighting the importance of this treatment approach in clinical practice.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response

Claudia Montaldo et al.

Summary: The study focused on analyzing extracellular vesicles (EVs) from healthy donors and HCV-infected patients before and after DAA treatment, revealing significant differences in miRNA and protein cargos between the two groups. The findings suggest that modifications in EVs could play a role in long-term liver disease progression in patients with HCV despite achieving virological cure.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study

Viola Knop et al.

Summary: Following DAA-induced eradication of HCV, liver stiffness decreased in patients with cirrhosis, while spleen stiffness remained unchanged. Liver stiffness continued to decline in a considerable proportion of patients with advanced liver disease, indicating potential regression of cirrhosis and portal hypertension.

JOURNAL OF VIRAL HEPATITIS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

Elton Dajti et al.

Summary: The study found that spleen stiffness measurement predicts the risk of hepatocellular carcinoma development in patients with liver disease treated with DAAs. An algorithm based on LSM and SSM values can stratify the risk of HCC development in patients after achieving SVR.

JHEP REPORTS (2021)

Add to Collection

Article Urology & Nephrology

Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease

Meghan E. Sise et al.

KIDNEY INTERNATIONAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals

Monica Pons et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents

Manuel Mendizabal et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance

Francesco Paolo Russo et al.

JOURNAL OF VIRAL HEPATITIS (2020)

Add to Collection

Review Gastroenterology & Hepatology

Postsustained Virological Response Management in Hepatitis C Patients

Chiara Masetti et al.

SEMINARS IN LIVER DISEASE (2020)

Add to Collection

Article Multidisciplinary Sciences

Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients

Man Yuan et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis

Angelo Sangiovanni et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension

Sabela Lens et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

EASL recommendations on treatment of hepatitis C: Final update of the series

Jean-Michel Pawlotsky et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Fabrice Carrat et al.

LANCET (2019)

Add to Collection

Article Gastroenterology & Hepatology

The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection

Hashem B. El-Serag et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Elisabetta Degasperi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Article Medicine, Research & Experimental

Exosomal Transmission of MicroRNA from HCV Replicating Cells Stimulates Transdifferentiation in Hepatic Stellate Cells

Ji Hyun Kim et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy

N. Saraiya et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

Patrice Cacoub et al.

AMERICAN HEART JOURNAL (2018)

Add to Collection

Article Immunology

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Raymond T. Chung et al.

CLINICAL INFECTIOUS DISEASES (2018)

Add to Collection

Article Gastroenterology & Hepatology

Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure

Martin Bonacci et al.

GASTROENTEROLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen

Hamish Innes et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

George N. Ioannou et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Hematology

Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis

T. Sinegre et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Add to Collection

Article Gastroenterology & Hepatology

Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals

Francesco Paolo Russo et al.

LIVER INTERNATIONAL (2018)

Add to Collection

Review Gastroenterology & Hepatology

Changing Concepts of Cirrhotic Coagulopathy

Armando Tripodi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Pierre Nahon et al.

GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Fasiha Kanwal et al.

GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

Adriaan J. van der Meer et al.

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Review Gastroenterology & Hepatology

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

Reem Waziry et al.

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Correction Virology

Exosome Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells (vol 91, e02225-16, 2017)

Pradip B. Devhare et al.

JOURNAL OF VIROLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

M. Bourliere et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Review Multidisciplinary Sciences

Hepatitis C virus and cardiovascular: A review

Salvatore Petta

JOURNAL OF ADVANCED RESEARCH (2017)

Add to Collection

Article Oncology

Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase

Ju Dong Yang et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies

Salvatore Petta et al.

GASTROENTEROLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

APASL consensus statements and recommendation on treatment of hepatitis C

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2016)

Add to Collection

Review Gastroenterology & Hepatology

Hepatitis C virus infection and chronic kidney disease: Time for reappraisal

Patrice Cacoub et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Letter Gastroenterology & Hepatology

High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis

Helder Cardoso et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Letter Gastroenterology & Hepatology

Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment

Karin Kozbial et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

Maria Reig et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis

J. Peveling-Oberhag et al.

JOURNAL OF VIRAL HEPATITIS (2016)

Add to Collection

Review Gastroenterology & Hepatology

Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Fabrizio Fabrizi et al.

DIGESTIVE DISEASES AND SCIENCES (2015)

Add to Collection

Article Multidisciplinary Sciences

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma

Ching-Sheng Hsu et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Gastroenterology & Hepatology

Natural history of hepatitis C

Rachel H. Westbrook et al.

JOURNAL OF HEPATOLOGY (2014)

Add to Collection

Review Medicine, General & Internal

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies

Rebecca L. Morgan et al.

ANNALS OF INTERNAL MEDICINE (2013)

Add to Collection

Article Multidisciplinary Sciences

Pegylated Interferon-α2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo

Hironori Kusano et al.

PLOS ONE (2013)

Add to Collection

Article Immunology

Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study

Mei-Hsuan Lee et al.

JOURNAL OF INFECTIOUS DISEASES (2012)

Add to Collection

Article Gastroenterology & Hepatology

Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus-Induced Cirrhosis. A 12-Year Prospective Follow-up Study

Savino Bruno et al.

HEPATOLOGY (2010)

Add to Collection

Article Gastroenterology & Hepatology

Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: Comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients

Fumio Imazeki et al.

LIVER INTERNATIONAL (2008)

Add to Collection

Article Gastroenterology & Hepatology

Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis

Stuart Roberts et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)

Add to Collection

Article Gastroenterology & Hepatology

Diabetes mellitus reduces the therapeutic effectiveness of interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C

Ichiro Konishi et al.

HEPATOLOGY RESEARCH (2007)

Add to Collection

Article Infectious Diseases

Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection

F Visnegarwala et al.

JOURNAL OF INFECTION (2005)

Add to Collection

Article Gastroenterology & Hepatology

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

M Romero-Gómez et al.

GASTROENTEROLOGY (2005)

Add to Collection

Article Virology

Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A population-based cohort study

H Watanabe et al.

JOURNAL OF MEDICAL VIROLOGY (2003)

Add to Collection

Article Medicine, General & Internal

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

MW Fried et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Add to Collection

Article Gastroenterology & Hepatology

Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population

LA Kondili et al.

GUT (2002)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation

DL Bigam et al.

HEPATOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.